Singapore markets open in 4 hours 4 minutes

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.22+0.54 (+2.49%)
As of 03:56PM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
20,147
14,240
0
203,196
117,912
Cost of revenue
2,592
1,704
-
2,805
1,317
Gross profit
17,555
12,536
-
200,391
116,595
Operating expenses
Research development
271,460
279,910
256,973
367,470
410,894
Selling general and administrative
120,670
121,673
121,445
149,070
132,034
Total operating expenses
392,130
401,583
378,418
516,540
542,928
Operating income or loss
-374,575
-389,047
-378,418
-316,149
-426,333
Interest expense
-
-
-
17,832
-
Total other income/expenses net
137,879
144,453
21,072
-
-
Income before tax
-210,045
-231,801
-356,510
-327,370
-411,472
Income from continuing operations
-210,045
-231,801
-356,510
-327,370
-411,472
Net income
-210,045
-231,801
1,604,715
-327,370
-411,472
Net income available to common shareholders
-210,045
-231,801
1,604,715
-327,370
-411,472
Basic EPS
-3.79
-4.23
26.55
-4.74
-6.86
Diluted EPS
-3.79
-4.23
26.55
-4.74
-6.86
Basic average shares
55,168
54,789
60,447
68,998
59,995
Diluted average shares
55,168
54,789
60,447
68,998
59,995